nervapax ApS: Financial statements 2025
CVR: 44342170
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
nervapax ApS (CVR 44342170) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -29,066 and a net result of DKK -151,030. Equity in the 2025 report amounted to DKK 445,234. The solvency ratio was 51.7%.
- Gross Profit
- DKK -29,066
- Profit/Loss
- DKK -151,030
- Equity
- DKK 445,234
- Total Assets
- DKK 861,906
- Employees
- 0
Official annual report
How creditworthy is nervapax ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nervapax ApS has published its interim report for the period October 2, 2023 – December 31, 2024.
About nervapax ApS
nervapax ApS is a Danish company of the type Anpartsselskab based in Hjallerup, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Fridel de Fries Laursen and Meike Claudia Sieburg. The company is owned by nervapax holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -29,066 and a net result of DKK -151,030. Equity in the 2025 report amounted to DKK 445,234.